IBO CIK: 1834105

Impact BioMedical Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−1.06
FY23:
–
FY24:
0
FY25:
−0.39
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−3.40
FY23:
−4.03
FY24:
−28.8
FY25:
−4.28
(positive)
Change from FY22 to FY23
millions USD
FY21:
–
FY22:
−2.20
FY23:
−2.84
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.88
FY22:
−7.88
FY23:
−4.41
FY24:
−24.7
FY25:
−14.5
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−7.26
FY23:
−4.34
FY24:
−24.7
FY25:
−11.8

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data